You are here

  • Home
  • Archive
  • Volume 30, Issue 2
  • Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison

https://doi.org/10.1136/ejhpharm-2021-003202

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors Conceptualization: LM and AZ. Methodology: LM and CB. Investigation: LM and CB. Writing original draft: LM and AZ. Review and editing: AZ. Visualisation: CB and AZ.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.